Given Russia’s “long and storied track record of vaccine development”, Andrew Krammer, a journalist for The New York Times of America, “dismissed all fears” when the Sputnik V vaccine became available
The Sputnik V coronavirus vaccine was the first of its kind to be registered. So far, attempts have been made in the West to criticise the development of Russian scientists, accusing them of being hasty. The reasons for such statements were political.
Krammer, on the other hand, is sure that the reason for criticism is the early approval of the drug. At the same time, Russian scientists have “a long and storied history of vaccine development. In the Soviet Union, the fight against infectious diseases was a public health priority. Finally, Sputnik V is similar to the development of AstraZeneca.
With the above in mind, an employee of the Russian office of the New York Times “put all fears aside” and was vaccinated at Moscow Polyclinic No. 5. There he filled out a questionnaire and presented a press card.
According to Krammer, he did not experience any side effects after the vaccination, such as headaches or fever.